Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing
- PMID: 12150906
- DOI: 10.1016/s1097-2765(02)00572-5
Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing
Abstract
Myotonic dystrophy type 1 (DM1) is a dominant multisystemic disorder caused by a CTG expansion in the 3' untranslated region of the DMPK gene. A predominant characteristic of DM1 is myotonia resulting from skeletal muscle membrane hyperexcitability. Here we demonstrate loss of the muscle-specific chloride channel (ClC-1) mRNA and protein in DM1 skeletal muscle tissue due to aberrant splicing of the ClC-1 pre-mRNA. The splicing regulator, CUG binding protein (CUG-BP), which is elevated in DM1 striated muscle, binds to the ClC-1 pre-mRNA, and overexpression of CUG-BP in normal cells reproduces the aberrant pattern of ClC-1 splicing observed in DM1 skeletal muscle. We propose that disruption of alternative splicing regulation causes a predominant pathological feature of DM1.
Similar articles
-
Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy.Mol Cell. 2002 Jul;10(1):35-44. doi: 10.1016/s1097-2765(02)00563-4. Mol Cell. 2002. PMID: 12150905
-
Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation.EBioMedicine. 2015 Jul 31;2(9):1034-47. doi: 10.1016/j.ebiom.2015.07.028. eCollection 2015 Sep. EBioMedicine. 2015. PMID: 26501102 Free PMC article.
-
Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy.J Gen Physiol. 2007 Jan;129(1):79-94. doi: 10.1085/jgp.200609635. Epub 2006 Dec 11. J Gen Physiol. 2007. PMID: 17158949 Free PMC article.
-
An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I.Genes (Basel). 2020 Sep 22;11(9):1109. doi: 10.3390/genes11091109. Genes (Basel). 2020. PMID: 32971903 Free PMC article. Review.
-
Myotonic dystrophy: emerging mechanisms for DM1 and DM2.Biochim Biophys Acta. 2007 Feb;1772(2):195-204. doi: 10.1016/j.bbadis.2006.05.013. Epub 2006 Jun 20. Biochim Biophys Acta. 2007. PMID: 16876389 Review.
Cited by
-
Erythromycin for myotonic dystrophy type 1: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.EClinicalMedicine. 2023 Dec 26;67:102390. doi: 10.1016/j.eclinm.2023.102390. eCollection 2024 Jan. EClinicalMedicine. 2023. PMID: 38314057 Free PMC article.
-
Smaug/SAMD4A restores translational activity of CUGBP1 and suppresses CUG-induced myopathy.PLoS Genet. 2013 Apr;9(4):e1003445. doi: 10.1371/journal.pgen.1003445. Epub 2013 Apr 18. PLoS Genet. 2013. PMID: 23637619 Free PMC article.
-
Rational design of bioactive, modularly assembled aminoglycosides targeting the RNA that causes myotonic dystrophy type 1.ACS Chem Biol. 2012 Dec 21;7(12):1984-93. doi: 10.1021/cb3001606. Epub 2012 Nov 7. ACS Chem Biol. 2012. PMID: 23130637 Free PMC article.
-
The exon 29 c.3535A>T in the alpha-2-macroglobulin gene causing aberrant splice variants is associated with mastitis in dairy cattle.Immunogenetics. 2012 Nov;64(11):807-16. doi: 10.1007/s00251-012-0639-8. Epub 2012 Aug 26. Immunogenetics. 2012. PMID: 22923050
-
Muscleblind-like1 undergoes ectopic relocation in the nuclei of skeletal muscles in myotonic dystrophy and sarcopenia.Eur J Histochem. 2013 Apr 22;57(2):e15. doi: 10.4081/ejh.2013.e15. Eur J Histochem. 2013. PMID: 23807294 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical